Over an average of 5 years of follow-up, the DFS rate reached 80%, and the OS rate was 88%.26 Another regimen of IMAP (IFO, mitomycin, ADM, and DDP) plus granulocyte-macrophage colony-stimulating factor followed by preoperative irradiation and subsequent limb-sparing surgery is satisfactory as initial treatment for primary extremity STSs.27 In our study, the combined use of DDP + IFO + ADM can effectively control tumor cell proliferation. Here, CSF2 is linked to neoplasm.